Evidence-based child health

Rosalind L. Smyth Β· Forfar & Arneil 7th Edition | EBM, Systematic reviews, RCTs, Likelihood ratios, Bayes, Diagnostic tests, Therapy, Cochrane Library
πŸ“Œ Core principles: Integration of best research evidence with clinical expertise & patient values. Hierarchy of evidence (SR of RCTs > RCT > cohort > case-control). Likelihood ratios & Bayes theorem guide diagnostic reasoning. Systematic reviews (Cochrane) reduce bias.

πŸ“– Evidence-Based Child Health: Core Concepts

πŸ”¬ Definition (Sackett)
Integration of clinical information from patient + best clinical research evidence + clinical experience. Art of medicine and objective science.
πŸ“ Likelihood Ratio (LR)
LR+ = sensitivity/(1-specificity). LR- = (1-sensitivity)/specificity. Post-test odds = pretest odds Γ— LR. Helps interpret diagnostic tests.
πŸ“š Hierarchy of evidence
1a: SR of RCTs; 1b: individual RCT (narrow CI); 2a: SR of cohort; 3: case-control; 4: case-series; 5: expert opinion.
πŸ”„ Systematic Review (Cochrane)
Rigorous methodology: prospective protocol, comprehensive search, quality assessment, meta-analysis if appropriate. Reduces bias vs narrative reviews.
πŸ§ͺ Bayesian thinking
Prior probability β†’ updated with evidence β†’ posterior probability. Natural framework for clinical decision making (diagnosis & therapy).
πŸ“ˆ Key example: Celiac disease – pretest prob 10% β†’ IgA-TTG LR+ 94 β†’ post-test prob 91% β†’ biopsy indicated. Negative LR- 0.06 β†’ prob 0.7% β†’ biopsy avoided.

πŸ” Using EBM to approach a clinical symptom: 5-step framework

1
Formulate an answerable clinical question – PICO: Population (child with cough), Intervention (antibiotic), Comparison (placebo), Outcome (pneumonia resolution).
2
Search for best evidence – Cochrane Library, PubMed/MEDLINE, TRIP database, clinical guidelines. Use systematic reviews when available.
3
Critically appraise evidence – For therapy: RCT blinding, allocation concealment, intention-to-treat, effect size. For diagnosis: independent blind comparison to gold standard, spectrum of patients, reproducibility.
4
Apply to patient – Is the evidence applicable? Is my patient similar to study population? Assess benefits vs harms, patient values.
5
Evaluate performance – Monitor outcomes, update knowledge, reflect on clinical decision.
πŸ“Œ Clinical pearl: Likelihood ratios are more informative than sensitivity/specificity alone. Use Fagan nomogram or online calculators to convert pretest to post-test probability.

🩺 Stepwise management: integrating EBM into child health decisions

1
Identify evidence gap – Ask focused question (e.g., β€œDoes asthma education delivered by nurse reduce ED visits?”).
2
Access pre-appraised resources – Cochrane systematic reviews, Clinical Evidence, AAP/ SIGN guidelines.
3
Critique study design & bias – Level 1 evidence (RCT/SR) preferred. For therapy: concealment, blinding, completeness of follow-up.
4
Calculate NNT/NNH if possible – Number needed to treat = 1/ARR (absolute risk reduction). Example: if ARR=10% β†’ NNT=10.
5
Apply shared decision-making – Present benefits/risks to family, incorporate child’s preferences, consider feasibility and costs.
6
Reassess & audit – Evaluate clinical outcomes, update practice as new high-level evidence emerges (living systematic reviews).
⚠️ Common pitfalls: Relying on narrative reviews, ignoring confidence intervals, overinterpreting p-values, therapeutic misconception, publication bias. Always check for heterogeneity in meta-analysis.

🧠 Reflex prompts: evidence-based child health in action

πŸ“Š You order a diagnostic test with LR+ = 20. Pretest probability = 30% β†’ post-test probability?
Pretest odds = 0.3/0.7=0.43 β†’ post-test odds = 0.43Γ—20=8.6 β†’ probability β‰ˆ 90% β†’ strong rule-in.
πŸ“‰ A systematic review of RCTs shows heterogeneity (IΒ²=85%). Next step?
Explore sources of heterogeneity (different populations, interventions), consider random-effects model, avoid pooling if clinically diverse.
🎯 Which study design best answers therapy question?
Randomized controlled trial (RCT) with concealment, blinding, and intention-to-treat analysis. Systematic review of RCTs provides highest level.
πŸ“š β€œAll-or-none” evidence (Level 1c)
Example: when all patients died before therapy, now some survive; or some died before, now none die. Very powerful observational evidence.
πŸ” Sensitivity vs specificity – which rules out disease?
High sensitivity test (SnNout): negative result rules OUT disease. High specificity test (SpPin): positive result rules IN disease.
πŸ“Œ Cochrane Library key features
2900+ systematic reviews (2006), updated quarterly, minimizes bias. Cochrane Child Health Field supports pediatric reviews.
⚠️ Why are many pediatric RCTs underpowered?
Smaller disease incidence, ethical constraints, heterogeneity of age, lack of validated pediatric outcome measures. Call for multicenter trials and networks (MCRN).
πŸ“ˆ Bayesian reasoning in clinical history
Each piece of history updates disease probability. Like β€œDr Jenkins’ hunch” – mother’s word β€œstrangely” raised pretest probability for meningococcal sepsis.